Skip to content

Opening book details…

About this Medicine article

T-24 Retreatment with telaprevir/Peg-IFN/RBV after a short exposure to telaprevir in Phase I studies: interim results from a Phase IIIb rollover trial (C219) by G. Picchio; C. Sarrazin; H.W. Reesink; S. Zeuzem; C.J. Weegink; D. Luo; J. Witek; T.L. Kieffer; D. Bartels; I. Dierynck; S. De Meyer is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
G. Picchio; C. Sarrazin; H.W. Reesink; S. Zeuzem; C.J. Weegink; D. Luo; J. Witek; T.L. Kieffer; D. Bartels; I. Dierynck; S. De Meyer
Publisher
Elsevier Science; Elsevier ; W. B. Saunders Co., Ltd.; Elsevier BV (ISSN 1590-8658)
Published
2012
Language
EN
Field
Medicine (Health Sciences)

More by G. Picchio; C. Sarrazin; H.W. Reesink; S. Zeuzem; C.J. Weegink; D. Luo; J. Witek; T.L. Kieffer; D. Bartels; I. Dierynck; S. De Meyer

Browse all works by G. Picchio; C. Sarrazin; H.W. Reesink; S. Zeuzem; C.J. Weegink; D. Luo; J. Witek; T.L. Kieffer; D. Bartels; I. Dierynck; S. De Meyer